All inactivating BIRC3 mutations detected in CLL are predicted to cause the elimination or truncation of the C-terminal RING domain, the E3 ubiquitin ligase activity which is essential for NIK proteasomal degradation. Here, BIRC3 is linked to B-cell chronic lymphocytic leukemia.